Comparison of Monitors of Fluid Therapy

Hypovolemia Clinical Trial

Official title:

Comparison of Monitors of Fluid Therapy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00286338
• Other study ID #: des.prost-1
• Status: Completed
• Phase: Phase 4
• First received: February 1, 2006
• Last updated: January 13, 2009
• Start date: February 2006
• Est. completion date: April 2006

Study information

• Verified date: January 2009
• Source: Rigshospitalet, Denmark
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: National Board of Health
• Study type: Observational

Clinical Trial Summary

The investigators want to correlate different methods to guide fluid therapy. The investigators know that guidance by esophagus doppler technique has improved outcome and want to correlate other already used techniques to esophagus doppler.

Description:

Fluid therapy before and under surgery can be guided by measurement of the hearts ability to eject blood (cardiac output). By doing this it has been shown that the occurrence of nausea,vomiting and complications generally can be reduced. The function of the heart has been measured with a probe in the esophagus in in earlier studies. We want to correlate these results with other techniques by which fluid therapy also is guided in daily practice. These are: SVO2, modelflow (finapres)and NIRS.

These methods are noninvasive except SVO2 measurement which requires a central venous catheter (CVK). Therefore we have chosen a population in which CVK is standard in our institution. We thereby don´t apply any further risks than daily practice and the project is considered as a quality assessment of used standards.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 12
• Est. completion date: April 2006
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Age 18 years or older

• Elective urological surgery in which a central venous catheter is routinely administered

• Informed consent

Exclusion Criteria:

• Age 70 years or older

• No informed consent

• Pathology in the esophagus that contraindicates use off gastric tube and esophagus doppler

• ASA III or above

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Hypovolemia

Locations

Country	Name	City	State
Denmark	Dept of anesthesia 2041, ABD centre, Rigshospitalet, Blegdamsvej	Copenhagen

Sponsors (1)

Lead Sponsor	Collaborator
Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark,